Additionally, we observed increased enrichment of sgRNAs targeting components of the p53 pathway in aneuploid cells compared with diploids, indicating that aneuploid cells derive greater benefit from loss of commonly mutated tumor suppressors. The gene discussed is TP53; the disease is neoplasm.